GENFLOW BIOSCIENCES PLC Logo

GENFLOW BIOSCIENCES PLC

Develops gene therapies to slow aging and treat age-related diseases in humans and dogs.

GENF | IL

Overview

Corporate Details

ISIN(s):
GB00BP2C3V08
LEI:
213800HVOFXRXVEGDN62
Country:
United Kingdom
Address:
6 HEDDON STREET, W1B 4BT LONDON
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Genflow Biosciences PLC is a preclinical biotechnology company focused on longevity science. Founded in 2020, the firm develops gene therapies designed to halt or slow the aging process and treat age-related diseases in both humans and dogs. Its core therapeutic approach centers on its lead compound, GF-1002, which delivers a centenarian variant of the SIRT6 gene, a key gene associated with exceptional longevity. The company's mission is to extend healthspan by intervening directly in the biological mechanisms of aging, with its programs demonstrating promising preclinical results.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-02 13:37
Share Issue/Capital Change
Issue of Equity - Correction
English 33.2 KB
2025-10-02 08:59
Director's Dealing
Issue of Equity
English 32.5 KB
2025-09-19 13:40
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-09-19 08:00
Regulatory News Service
Genflow Strengthens IP Portfolio
English 16.7 KB
2025-09-15 08:00
Regulatory News Service
Genflow Signs CDAs with Animal Health Companies
English 17.6 KB
2025-08-27 16:07
Major Shareholding Notification
Holding(s) in Company
English 21.7 KB
2025-08-18 08:00
Regulatory News Service
Company Update on Dog Trials
English 19.7 KB
2025-07-24 08:00
Earnings Release
Clinical Readiness Acceleration
English 17.7 KB
2025-07-17 08:00
Capital/Financing Update
Genflow Confirms Progression of Grant
English 18.0 KB
2025-06-12 11:16
Post-Annual General Meeting Information
Result of AGM
English 30.5 KB
2025-05-28 08:00
Regulatory News Service
Genflow Signs Master Services Agreement
English 13.4 KB
2025-05-15 08:00
Regulatory News Service
Key SIRT6 Patent Application
English 12.3 KB
2025-05-12 11:50
Major Shareholding Notification
Holding(s) in Company
English 68.7 KB
2025-05-07 19:07
Annual Report (ESEF)
Annual financial statements 2024
English 493.4 KB
2025-05-07 19:07
Annual Report
Annual financial statements 2024
English 1.5 MB

Automate Your Workflow. Get a real-time feed of all GENFLOW BIOSCIENCES PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GENFLOW BIOSCIENCES PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.